CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
Blood Adv
; 8(7): 1600-1611, 2024 Apr 09.
Article
in En
| MEDLINE
| ID: mdl-37878808
Full text:
1
Database:
MEDLINE
Main subject:
Multiple Myeloma
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Year:
2024
Type:
Article